HomeHealth TopicsGenetics Birth DefectsTay-Sachs Disease
Back to Genetics Birth Defects
Tay-Sachs Disease
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Genetics Birth Defects

Tay-Sachs Disease

Tay-Sachs disease is a rare, inherited lipid metabolism disorder that causes a fatal buildup of fatty substances in the brain.

Overview

Tay-Sachs disease is a lipid metabolism disorder that causes an accumulation of a fatty substance in the brain, which destroys nerve cells. Infants typically appear to develop normally for the first few months of life before experiencing a decline in mental and physical abilities.

Progression and Symptoms

As the disease progresses, children become blind, deaf, and unable to swallow. Muscles waste away and paralysis sets in. Even with optimal care, children with Tay-Sachs disease usually die by age 4.

Causes and Diagnosis

The disease is caused by a gene mutation, which is most common in Eastern European Ashkenazi Jews. It is an inherited condition; both parents must carry the gene for a child to have a 25% chance of developing the disease. Diagnosis can be confirmed through blood tests and prenatal testing.

Treatment

There is no cure for Tay-Sachs disease. Management focuses on providing comfort through medicines and good nutrition, which may include the use of feeding tubes.

Frequently Asked Questions

Early involvement of a pediatric gastroenterologist and speech‑language pathologist is key. A feeding evaluation may lead to placement of a gastrostomy tube (G‑tube) for safe nutrition, while positioning strategies, thickened feeds, and suctioning reduce aspiration risk. Regular monitoring of weight and respiratory status is critical.
Carrier screening uses a blood or saliva sample to analyze the HEXA gene for common Ashkenazi Jewish mutations and other ethnic‑specific variants. The test detects >99 % of known pathogenic alleles, providing a reliable risk assessment for couples planning pregnancy.
Prenatal diagnosis can be performed via chorionic villus sampling (10‑12 weeks) or amniocentesis (15‑18 weeks) to analyze fetal DNA for HEXA mutations. A positive result confirms the disease; families may consider continuation with palliative planning, pregnancy termination, or adoption, depending on personal, religious, and legal factors. Genetic counseling is essential to discuss these choices.
Palliative care focuses on pain control (e.g., low‑dose opioids for discomfort), seizure management, and maintaining oral hygiene to prevent infections. Gentle physical therapy, music therapy, and family presence support emotional well‑being. A hospice team can coordinate home nursing, equipment, and counseling for caregivers.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

kontakt@hittavard.se

Ⓒ 2024. Alla rättigheter förbehålls av juxt ab

Sök
Om ossVillkor och policyVanliga frågorKontakta oss